Circulation Reports
Online ISSN : 2434-0790
Imaging
Tissue Mitral Annular Displacement in Patients With Myocardial Infarction ― Comparison With Global Longitudinal Strain ―
Katsuomi IwakuraToshinari OnishiAtsunori OkamuraYasushi KoyamaKoichi InoueHiroyuki NagaiYuko HiraoKoji TanakaMutsumi IwamotoNobuaki TanakaDaisaku NakataniShungo HikosoYasuhiko SakataYasushi SakataKenshi Fujii
著者情報
ジャーナル オープンアクセス HTML
電子付録

2021 年 3 巻 9 号 p. 530-539

詳細
抄録

Background:Global longitudinal strain (GLS) can predict prognosis after myocardial infarction (MI). Tissue mitral annular displacement (TMAD) is another index of longitudinal left ventricular deformity, and is less dependent on image quality than GLS. We investigated the relationship between TMAD and GLS, and their ability to predict outcomes after MI.

Methods and Results:GLS and TMAD were measured on echocardiograms 2 weeks after MI in 246 consecutive patients (median age 62 years, 85.7% male). TMAD was measured from apical 4- and 2-chamber views (TMAD4chand TMAD2ch, respectively), and a mean value (TMADav) was calculated. TMAD4ch, TMAD2ch, and GLS were successfully measured in 240 (97.5%), 210 (85.3%) and 214 patients (87.0%), respectively. All TMAD parameters were significantly correlated with GLS (R=0.71–0.75) and left ventricular ejection fraction (LVEF; R=0.48–0.53). TMAD parameters were weakly correlated with peak creatine kinase (CK; R=0.20) and CK-MB (R=0.21–0.25). GLS and TMADavwere significantly associated with LVEF after 6 months (R=0.48–0.53) and all-cause mortality during the follow-up period (median 1,242 days). TMADavdiscriminated patients with higher all-cause mortality when patients were divided into 3 groups, namely upper 25%, middle range, and lower 25% of TMADav(P=0.041, log-rank test). GLS detected high-risk patients using 15.0% as a cut-off value.

Conclusions:TMAD could be a simple and reliable alternative to GLS for predicting outcomes in patients with MI.

著者関連情報
© 2021, THE JAPANESE CIRCULATION SOCIETY

This article is licensed under a Creative Commons [Attribution-NonCommercial-NoDerivatives 4.0 International] license.
https://creativecommons.org/licenses/by-nc-nd/4.0/
前の記事 次の記事
feedback
Top